Status | Study |
Enrolling by invitation |
Study Name: Natural History of Pearson Syndrome Condition: Pearson Syndrome Date: 2014-12-22 |
Terminated |
Study Name: Phase 2 Study of EPI-743 in Children With Pearson Syndrome Condition: Pearson Syndrome Date: 2014-04-02 Interventions: Drug: EPI-743 EPI-743 is the quinone oxidation product of alpha-tocotrienol |
Completed |
Study Name: Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment Condition: Dyskeratosis Congenita Fanconi Anemia Myelodysplastic Synd Date: 2007-07-10 Interventions: Genetic: polymerase chain reaction Other: |